Proven
Thymosin Alpha-1
The prediction game
Call it: rising or fading?
Where does Thymosin Alpha-1 stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: B (good evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 7.3/10
Thymosin Alpha-1 is a 7.3 / 10 fit for people discussing immune modulation with a clinician, especially in hospital-adjacent or immune-compromised contexts, not a casual immune booster for healthy people. The cleanest evidence anchors are [Cao 2024](https://pubmed.ncbi.nlm.nih.gov/39648386/), which pooled 39 acute COPD exacerbation RCTs, and [Wu 2025](https://pubmed.ncbi.nlm.nih.gov/39814420/), which found no clear 28-day mortality benefit in a large sepsis trial. [Tian 2025](https://pubmed.ncbi.nlm.nih.gov/40599771/) adds useful context: reported infection and immune-marker benefits in severe acute pancreatitis trials. The practical gap is the same one that shows up across the report: mechanism and early outcomes are more convincing than broad real-world certainty. In practice, Thymosin Alpha-1 belongs after the basics, works best when the target is specific, and deserves tracking around benefits, side effects, interactions, and cost before it becomes a standing protocol. ✅ Best for: Adults over 40 with signs of immune aging or poor vaccine response; frequent travelers exposed to airports, dense events, or ill contacts; people recovering from illness, surgery, or chemotherapy-associated immune suppression; patients with documented low CD4, poor CD4/CD8 ratio, low mHLA-DR, or lymphopenia; and chronic viral hepatitis or cancer patients only as adjunctive care under the relevant specialist. TA-1 is strongest when there is an immune deficit to normalize, not when a healthy young user wants a dramatic daily effect. ❌ Avoid if: You have active autoimmune disease, recent autoimmune flare, transplant history, immunosuppressive therapy, pregnancy, lactation, or no way to verify sterile sourcing and peptide identity. Avoid replacing first-line hepatitis B, sepsis, COPD, pancreatitis, COVID-19, or cancer care with TA-1. Competitive athletes should avoid unsupervised use unless a qualified anti-doping expert clears the jurisdiction-specific S0 risk. Healthy under-30 users with robust immune function should usually spend the money on sleep, exercise, nutrition, vaccines, and travel hygiene first.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
In the news this week: Claudia von Boeselager, Jay Campbell.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Proven
- Trend
- Begins with Edition 2
- Momentum
- 0.1%
- BioHarmony Score
- 7.3/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.